XL
Insider
10X Capital Management, LLC
10% owner10X Capital Management, LLC (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $921K of GALT (162,069 sh across 2 lots, as filed), executed Dec 2 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.1M
shares × price, as filed
Last traded
Dec 3 2025
Filed Dec 4 2025
Median ADV $2.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
GALTRecent filings
GALTSALE
Galectin Therapeutics Inc.
View filing →
$852K150,000 sh across 2 lots
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. View filing → $921K
162,069 sh across 2 lots
Exec Dec 2 2025
Filed Dec 8 2025 · 5:30 PM ET † GALTSALE Galectin Therapeutics Inc. View filing → $210K
40,000 sh × $5.25
Exec Nov 11 2025
Filed Nov 12 2025 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. View filing → $148K
30,000 sh × $4.94
Exec Oct 22 2025
Filed Oct 24 2025 · 5:30 PM ET